Skip to content

Company information lookup

MESOBLAST LIMITED (MSB)

A biotechnology company in the area of adult stem cell technology.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
MSB 3.750 0% 3.720 3.880 0.000 0.000 0.000 0

MESOBLAST LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code MSB
Securities
Official Listing Date 16 December, 2004
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.mesoblast.com
Registered Office Address Level 38, 55 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000
Head Office Telephone (03) 9639 6036
Head Office Fax (03) 9639 6030
Share Registry LINK MARKET SERVICES LIMITED
LEVEL 1, 333 COLLINS STREET, MELBOURNE, VIC, AUSTRALIA, 3000
Share Registry Telephone 1300 554 474
Directors / Senior Management
Mr Brian Jamieson (Non Exec. Chairman, Non Exec. Director)
Mr Donal O'Dwyer (Deputy Chairman, Non Exec. Director)
Prof. Silviu Itescu (Managing Director, CEO)
Mr William M Burns (Non Exec. Director)
Dr Eric A Rose (Non Exec. Director)
Mr Michael Spooner (Non Exec. Director)
Dr Ben - Zion Weiner (Non Exec. Director)
Company Secretary Mr Charlie Harrison
Principal Activities A biotechnology company in the area of adult stem cell technology.

MESOBLAST LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
23/10/2014   Notice of Annual General Meeting/Proxy Form 14 PDF
23/10/2014   Annual Report to shareholders 116 PDF
01/10/2014 asterix MSB PARTNER JCR FILES FOR PRODUCT APPROVAL 2 PDF
26/09/2014   Appendix 3B 9 PDF
29/08/2014   Company Secretary Appointment/Resignation 1 PDF
26/08/2014   MSB 2014 Annual Financial Results Presentation 28 PDF
26/08/2014 asterix MSB Unveils Path to Bring its Key Products to Market 3 PDF
26/08/2014 asterix Preliminary Final Report 98 PDF
25/08/2014   Pharmaceutical Executive Appointed as Mesoblast CFO 1 PDF
22/08/2014   Change of Director's Interest Notice 2 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
23 Oct 2014 3.750 -1.57% 3.780 3.710 295,768
22 Oct 2014 3.810 1.6% 3.850 3.700 417,847
21 Oct 2014 3.750 -3.85% 3.900 3.730 507,405
20 Oct 2014 3.900 -1.02% 4.060 3.880 389,120
17 Oct 2014 3.940 4.51% 3.970 3.780 350,050

* Volume of shares shown represents only those shares traded on ASX.

MESOBLAST LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security MSB. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security MSB

Warrants & Structured Products

Warrants & Structured Products are available over the security MSB. Click here to view the current warrant issue details.